Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

Autor: Adarraga, MD, Alberich-Conesa, A, Aibar, J, Alda-Lozano, A, Alfonso, J, Amado, C, Angelina-García, M, Arcelus, JI, Ballaz, A, Barba, R, Barbagelata, C, Barrón, M, Barrón-Andrés, B, Beddar-Chaib, F, Blanco-Molina, A, Caballero, JC, Castellanos, G, Criado, J, De Ancos, C, Del Toro, J, Demelo-Rodríguez, P, De Juana-Izquierdo, C, Díaz-Peromingo, JA, Dubois-Silva, A, Escribano, JC, Falgá, C, Farfán-Sedano, AI, Fernández-Aracil, C, Fernández-Capitán, C, Fernández-Jiménez, B, Fernández-Reyes, JL, Fidalgo, MA, Francisco, I, Gabara, C, Galeano-Valle, F, García-Bragado, F, García-Ortega, A, Gavín-Sebastián, O, Gil-Díaz, A, Gómez-Cuervo, C, González-García, C, González-Munera, A, Grau, E, Guirado, L, Gutiérrez-Guisado, J, Hernández-Blasco, L, Herreros, M, Jara-Palomares, L, Jaras, MJ, Jiménez, D, Jou, I, Joya, MD, Lecumberri, R, Llamas, P, Lobo, JL, López-Jiménez, L, López-Miguel, P, López-Brull, H, López-Núñez, JJ, López-Ruiz, A, López-Sáez, JB, Lorenzo, A, Lumbierres, M, Madridano, O, Maestre, A, Marchena, PJ, Marcos, M, Martín del Pozo, M, Martín-Martos, F, Martínez-Prado, R, Maza, JM, Mena, E, Mercado, MI, Moisés, J, Molino, A, Monreal, M, Morales, MV, Navas, MS, Nieto, JA, Núñez-Fernández, MJ, Olid, M, Ordieres-Ortega, L, Ortiz, M, Osorio, J, Otálora, S, Otero, R, Pacheco-Gómez, N, Pagán, J, Palomeque, AC, Paredes, E, Parra-Caballero, P, Pedrajas, JM, Pérez-Ductor, C, Pérez-Pinar, M, Peris, ML, Pesce, ML, Porras, JA, Puchades, R, Rivera-Cívico, F, Rodríguez-Cobo, A, Romero-Brugera, M, Ruiz-Artacho, P, Ruiz-Giménez, N, Ruiz-Ruiz, J, Salgueiro, G, Sancho, T, Sendín, V, Sigüenza, P, Soler, S, Steinherr, A, Suárez-Fernández, S, Tirado, R, Torrents-Vilar, A, Torres, MI, Trujillo-Santos, J, Uresandi, F, Valle, R, Varona, JF, Villalobos, A, Villares, P, Ay, C, Nopp, S, Pabinger, I, Vanassche, T, Verhamme, P, Verstraete, A, Yoo, HHB, Montenegro, AC, Morales, SN, Roa, J, Hirmerova, J, Malý, R, Bertoletti, L, Bura-Riviere, A, Catella, J, Chopard, R, Couturaud, F, Espitia, O, Grange, C, Le Mao, R, Leclercq, B, Mahé, I, Morange, P, Moustafa, F, Plaisance, L, Sarlon-Bartoli, G, Suchon, P, Versini, E, Schellong, S, Brenner, B, Dally, N, Kenet, G, Tzoran, I, Sadeghipour, P, Rashidi, F, Abenante, A, Barillari, G, Basaglia, M, Bertoni, M, Bilora, F, Brandolin, B, Ciammaichella, M, Colaizzo, D, Dentali, F, Di Micco, P, Grandone, E, Imbalzano, E, Negro, F, Pesavento, R, Poz, A, Prandoni, P, Siniscalchi, C, Taflaj, B, Tufano, A, Visonà, A, Zalunardo, B, Skride, A, Kigitovica, D, Zicans, M, Fonseca, S, Marques, R, Meireles, J, Pinto, S, Bosevski, M, Trajkova, M, Zdraveska, M, Bounameaux, H, Mazzolai, L, Aujayeb, A, Caprini, JA, Weinberg, I, Bui, HM, Cohen, Omri, Waldman Radinsky, Liat, Kenet, Gili, Mahé, Isabelle, Barillari, Giovanni, Soler, Silvia, Sigüenza, Patricia, Del Valle Morales, María, Villares, Paula, Monreal, Manuel

Publikováno v: In Blood Advances 24 September 2024 8(18):4950-4959

Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

Autor: Pablo Demelo‐Rodriguez, Ana Isabel Farfán‐Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, María Jesús Jaras, Manuel Quintana‐Diaz, Carmen Fernández‐Capitán, Behnood Bikdeli, David Jiménez, Manuel Monreal, Adarraga D, Aibar J, Baeza C, Ballaz A, Barba R, Blanco‐Molina A, Botella E, Criado J, Demelo‐Rodríguez P, Díaz‐Brasero AM, de Ancos C, del Toro J, Farfán‐Sedano AI, Fernández‐Capitán C, Fidalgo A, Flores K, Gabara C, Galeano‐Valle F, Gavín‐Sebastián O, Gil‐Díaz A, Jaras MJ, Jara‐Palomares L, Jiménez R, Lainez‐Justo S, Latorre A, Lecumberri R, Llamas P, Lobo JL, López‐Jiménez L, Loureiro B, Madridano O, Mancebo‐Plaza AB, Martín del Pozo M, Monreal M, Muñoz‐Rivas N, Núñez‐Fernández MJ, Olivera PE, Ordieres‐Ortega L, Padín‐Paz EM, Pedrajas JM, Quintana‐Díaz M, Ríos‐Prego M, Rodríguez‐Chiaradía DA, Ruiz‐Artacho P, Sigüenza P, Suriñach JM, Trujillo‐Santos J, Zamora C, Bucherini E, Di Micco P, Imbalzano E, Siniscalchi C, Bosevski M, Stevanovic M, Paz‐Rios L, Weinberg I

Publikováno v: Journal of Thrombosis and Haemostasis

Introduction Some local protocols suggest using intermediate or therapeutic doses of anticoagulants for thromboprophylaxis in hospitalized patients with coronavirus disease 2019 (COVID‐19). However, the incidence of bleeding, predictors of major bl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b566944287b12832cf07470f48b433
https://doi.org/10.1111/jth.15400

Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial.

Autor: Morales-Ortega A; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.; Department of Medicine, Universidad de Alcalá, Madrid, Spain., Farfán-Sedano AI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., San Martín-López JV; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Escribá-Bárcena A; Department of Intensive Care Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Jaenes-Barrios B; Primary Health Care Center Castilla La Nueva, Madrid, Spain., Madroñal-Cerezo E; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Llarena-Barroso C; Department of Orthopaedic Surgery and Traumatology, Hospital Universitario de Fuenlabrada, Madrid, Spain., Mesa-Plaza N; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Frutos-Pérez B; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Ruiz-Giardín JM; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Duarte-Millán MÁ; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Piedrabuena-García SI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Carpintero-García L; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Canalejo-Castrillero E; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.; Department of Medical Specialties and Public Health, Universidad Rey Juan Carlos, Madrid, Spain., Mora-Hernández B; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., García-Parra CJ; Department of Emergency Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Magro-García HA; Department of Emergency Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Algaba-García A; Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain., Hernández-Muniesa B; Department of Hospital Pharmacy, Hospital Universitario de Fuenlabrada, Madrid, Spain., Nasarre-López B; Clinical Research Program, Spanish National Cancer Research Centre (CNIO)-Hospital Universitario de Fuenlabrada, Madrid, Spain., Ontañón-Nasarre A; Department of Hospital Pharmacy, Hospital Universitario de Fuenlabrada, Madrid, Spain., Domínguez-García MJ; Department of Emergency Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Gómez-Santos D; Department of Radiology, Hospital Universitario de Fuenlabrada, Madrid, Spain., Prieto-Menchero S; Department of Laboratory Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., García de Tena J; Department of Medicine, Universidad de Alcalá, Madrid, Spain., Bermejo F; Department of Medical Specialties and Public Health, Universidad Rey Juan Carlos, Madrid, Spain.; Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital La Paz (IdiPAZ), Madrid, Spain., García-Gil M; Department of Hospital Pharmacy, Hospital Universitario de Fuenlabrada, Madrid, Spain., Gonzalo-Pascua S; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.; Department of Medical Specialties and Public Health, Universidad Rey Juan Carlos, Madrid, Spain., Bernal-Bello D; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.

Publikováno v: Journal of medical virology [J Med Virol] 2023 Feb; Vol. 95 (2), pp. e28495.

Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.

Autor: Duarte-Millán MA; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Mesa-Plaza N; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Guerrero-Santillán M; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Morales-Ortega A; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Bernal-Bello D; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Farfán-Sedano AI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., García de Viedma-García V; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Velázquez-Ríos L; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Frutos-Pérez B; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., De Ancos-Aracil CL; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Soria Fernández-Llamazares G; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Toledano-Macías M; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Cristóbal-Bilbao R; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Luquín-Ciuro N; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Marrero-Francés J; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Piedrabuena-García SI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Satué-Bartolomé JA; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Gonzalo-Pascua S; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Rivilla-Jiménez M; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Carpintero-García L; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Ayala-Larrañaga I; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., García-Bermúdez V; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Lara-Montes C; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Llerena-Riofrío ÁR; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., RIvas-Prado L; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Walter S; Methodological Support Unit, Hospital Universitario de Fuenlabrada, Madrid, Spain., Escriba-Barcena A; Intensive Care Unit, Hospital Universitario de Fuenlabrada, Madrid, Spain., San Martín López JV; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Ruíz-Giardín JM; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.

Publikováno v: Journal of medical virology [J Med Virol] 2022 Apr; Vol. 94 (4), pp. 1540-1549. Date of Electronic Publication: 2021 Dec 07.

Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.

Autor: Demelo-Rodriguez P; Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Farfán-Sedano AI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Pedrajas JM; Department of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain., Llamas P; Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sigüenza P; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Jaras MJ; Department of Internal Medicine, Hospital Cantoblanco, Madrid, Spain., Quintana-Diaz M; Department of Intensive Care, Hospital Universitario La Paz, Madrid, Spain., Fernández-Capitán C; Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain., Bikdeli B; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut, USA.; Cardiovascular Research Foundation, New York, New York, USA., Jiménez D; Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá (IRYCIS), Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Monreal M; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Spain.; Universidad Católica de Murcia, Universidad Autònoma de Barcelona, CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Aug; Vol. 19 (8), pp. 1981-1989. Date of Electronic Publication: 2021 Jun 20.